Johnson & Johnson opioid trial judge expected to issue landmark verdict Monday [CNBC]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: CNBC
Johnson & Johnson opioid trial judge expected to issue landmark verdict Monday An judge is expected to issue what will be a landmark ruling Monday on whether The attorney general claims J&J and its pharmaceutical subsidiary Janssen aggressively marketed to doctors and downplayed the risks of opioids beginning in the 1990s. The company's sales practices created an oversupply of the addictive painkillers and "a public nuisance" that upended lives and will cost the state $12.7 billion to $17.5 billion, the state says. Attorney General Mike Hunter is urging Cleveland County District Judge Thad Balkman to force J&J to pay more than $17 billion in the first civil trial in the U.S. seeking to hold a drugmaker accountable for helping fuel the epidemic. The $17 billion — to be used as part of an abatement plan over 30 years — would provide funds for addiction treatment and prevention programs in the state, officials say. J&J has denied any wrongdoing, and there's always a chance it could
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Justice Department is investigating McKinsey consulting firm's role in opioid epidemic [CNN]CNN
- Are You Looking for a High-Growth Dividend Stock? [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson receives positive CHMP opinion for RYBREVANT®? (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations [Yahoo! FinaYahoo! Fina
- Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data [Seeking Alpha]Seeking Alpha
- AACN's New Web Resource Focuses on Preparing Nurses with Essential Well-Being and Leadership Competencies [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website